Anrikefon

Star0

DB21529InvestigationalSmall molecule

Anrikefon is a small molecule drug. Anrikefon has a monoisotopic molecular weight of 703.44 Da.

Mechanism: Pharmacologically active on Kappa-type opioid receptor
Curator reviewed
Formula / weight: C₃₉H₅₇N₇O₅ · 703.929 g/mol (avg)

Resolves to

Compound

UNII22SCY98BXVCAS2269511-95-5ChEMBLCHEMBL5095089

Structure

InChIKeyVWXDZAZSCZVCPV-YFRBGRBWSA-NSMILESCC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCCN)C(=O)N1CCC2(CN(C2)C(C)=O)CC1

Targets

P41145OPRK1

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Anrikefon, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account